Shanghai Healthcare Capital
- Series A
- Series B
- Series C
- Growth
About
Shanghai Healthcare Capital is a state-authorized private equity fund manager established to support the development of Shanghai as a global center for healthcare innovation. It is backed by several major state-owned enterprises and financial institutions in the Shanghai region. The firm is a key player in China’s industrial policy to upgrade its domestic medical manufacturing capabilities.
Shanghai Healthcare Capital centers its strategy on Cross-Border Synergy, facilitating the transfer of international medical innovation into the high-growth Chinese market. Their thesis focuses on clinical-stage pharmaceutical research and advanced medical devices that can be manufactured at scale within the Shanghai biotech cluster. They act as a strategic bridge for Western companies seeking to navigate China's complex regulatory and clinical trial environment.
The management team combines experience from healthcare operations, life sciences investing, and public-private initiatives in China. Leadership focuses on scaling medical innovation, hospital systems, and biopharma platforms within regulated healthcare markets.